Tag:
antisense
Latest Headlines
Latest Headlines
Pfizer adds to fibrosis drug pipeline with Excaliard buyout
Four years after opening shop with a $15.5 million Series A, Excaliard Pharmaceuticals is being snapped up by Pfizer ( $PFE ) after attracting the pharma giant's attention with a string of positive
Isis bags $1.53B rare disease development deal with GSK
Isis Pharmaceuticals bagged a potential blockbuster deal with GlaxoSmithKline, snagging a $35 million upfront and a potential payoff of up to $1.5 billion in exchange for deploying its antisense
More good news from RNAi company Isis
Isis has been on a good-news roll lately, and today is no exception. The company announced positive results from a Phase II open-label extension trial of of
